ASTRO’s first bladder cancer guideline recommends trimodal therapy as a curative option for selected patients and defines ...

From fronting The Jaggerz to scoring solo rock classics, the legendary Pennsylvania musician died following a battle with ...

Results from a large study show that adding two drugs, durvalumab and enfortumab vedotin, before bladder cancer surgery ...

The study enrolled 25 patients with high-grade bladder cancer that had come back after earlier BCG treatment. Their median ...

A gradient boosting machine model built on SEER data from 2,117 patients outperformed TNM staging in predicting survival in ...

The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...

The U.S. Food and Drug Administration has expanded the approved use of Anktiva (nogapendekin alfa inbakicept-pmln), given ...

VOLGA was conducted in patients with MIBC ineligible or unwilling to take platinum-based chemotherapy, who received PD-L1 inhibitor Imfinzi (durvalumab) before and after surgery to remove the tumour, ...

Anktiva is now approved for BCG-unresponsive papillary-only bladder cancer. Here’s what the bladder-sparing option involves, ...

A new combination of cancer medications appears to extend overall survival in patients with advanced bladder cancer more than the chemotherapies currently used as the standard of care. The research, ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today provided a summary of key findings from the European Society for Medical Oncology (ESMO) Congress 2026.